Metabolic reprogramming in esophageal squamous cell carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Cancer Metabolism

Background:

• Esophageal squamous cell carcinoma (ESCC) presents a significant health challenge, particularly in China, with poor patient prognosis due to limited effective molecular targets.
• Identifying novel therapeutic strategies is crucial for improving outcomes in ESCC patients.

Purpose of the Study:

• To review the metabolic reprogramming in ESCC cells within their tumor microenvironment.
• To explore the roles of altered glucose, lipid, and amino acid metabolism in ESCC.
• To identify potential biomarkers and therapeutic targets based on metabolic reprogramming.

Main Methods:

• Literature review summarizing current research on ESCC metabolism.
• Analysis of metabolic pathways including glucose, lipid, and amino acid metabolism.
• Discussion of the implications of metabolic reprogramming for ESCC pathogenesis.

Main Results:

• ESCC cells exhibit significant metabolic reprogramming to meet bioenergetic, biosynthetic, and redox homeostasis demands in hypoxic and nutrient-limited conditions.
• Key metabolic alterations involve glucose, lipid, and amino acid metabolism.
• Reprogrammed metabolism presents new avenues for biomarker discovery and therapeutic intervention.

Conclusions:

• Metabolic reprogramming is a critical hallmark of ESCC, influencing its biological features.
• Targeting metabolic pathways in ESCC offers promising opportunities for developing novel diagnostic and therapeutic approaches.